Global Conjugate Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 24-Jan-2019
No. of pages: 121
Inquire Before Buying

Conjugate vaccines are formed by covalently bonding a weak antigen to the strong antigen. It boosts the hosts' immune response. Conjugate vaccines are germ specific and can identify targeted germ only, so it can be used as a preventative measure to provide additional protection. Conjugate vaccines are used to treat Hib (Haemophilus influenzae type b) disease, Hepatitis B, HPV (Human papillomavirus), Whooping cough (part of the DTaP combined vaccine), Pneumococcal disease, Meningococcal disease, and Shingles.

The rising occurrence of diseases caused by microorganisms, increasing awareness about prevention of infectious diseases, and an increasing number of regulatory approvals to the vaccines are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by top players such as new product launches are contributing to the growth of the market.

The global Conjugate Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Conjugate Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Conjugate Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Conjugate Vaccine in these regions.

This research report categorizes the global Conjugate Vaccine market by top players/brands, region, type and end user. This report also studies the global Conjugate Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- GlaxoSmithKline

- Pfizer

- Merck

- Sanofi Pasteur

- CSL

- Emergent BioSolutions

- Johnson & Johnson

- Medimmune

- Astellas Pharma

- Serum Institute of India

- Bavarian Nordi

- Mitsubishi Tanabe Pharma

- Daiichi Sankyo Company

- Fablife

- SutroVax

- Sinovac Biotech

Market size by Product

- Monovalent

- Multivalent

Market size by End User

- Hospitals

- Clinics

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Conjugate Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Conjugate Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Conjugate Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Conjugate Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Conjugate Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Conjugate Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Conjugate Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Conjugate Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Conjugate Vaccine Market Size Growth Rate by Product
1.4.2 Monovalent
1.4.3 Multivalent
1.5 Market by End User
1.5.1 Global Conjugate Vaccine Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Conjugate Vaccine Market Size
2.1.1 Global Conjugate Vaccine Revenue 2014-2025
2.1.2 Global Conjugate Vaccine Sales 2014-2025
2.2 Conjugate Vaccine Growth Rate by Regions
2.2.1 Global Conjugate Vaccine Sales by Regions
2.2.2 Global Conjugate Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Conjugate Vaccine Sales by Manufacturers
3.1.1 Conjugate Vaccine Sales by Manufacturers
3.1.2 Conjugate Vaccine Sales Market Share by Manufacturers
3.1.3 Global Conjugate Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Conjugate Vaccine Revenue by Manufacturers
3.2.1 Conjugate Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Conjugate Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Conjugate Vaccine Price by Manufacturers
3.4 Conjugate Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Conjugate Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Conjugate Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Conjugate Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Conjugate Vaccine Sales by Product
4.2 Global Conjugate Vaccine Revenue by Product
4.3 Conjugate Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Conjugate Vaccine Breakdown Data by End User
6 North America
6.1 North America Conjugate Vaccine by Countries
6.1.1 North America Conjugate Vaccine Sales by Countries
6.1.2 North America Conjugate Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Conjugate Vaccine by Product
6.3 North America Conjugate Vaccine by End User
7 Europe
7.1 Europe Conjugate Vaccine by Countries
7.1.1 Europe Conjugate Vaccine Sales by Countries
7.1.2 Europe Conjugate Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Conjugate Vaccine by Product
7.3 Europe Conjugate Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Conjugate Vaccine by Countries
8.1.1 Asia Pacific Conjugate Vaccine Sales by Countries
8.1.2 Asia Pacific Conjugate Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Conjugate Vaccine by Product
8.3 Asia Pacific Conjugate Vaccine by End User
9 Central & South America
9.1 Central & South America Conjugate Vaccine by Countries
9.1.1 Central & South America Conjugate Vaccine Sales by Countries
9.1.2 Central & South America Conjugate Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Conjugate Vaccine by Product
9.3 Central & South America Conjugate Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Conjugate Vaccine by Countries
10.1.1 Middle East and Africa Conjugate Vaccine Sales by Countries
10.1.2 Middle East and Africa Conjugate Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Conjugate Vaccine by Product
10.3 Middle East and Africa Conjugate Vaccine by End User
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Conjugate Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Conjugate Vaccine Products Offered
11.2.5 Pfizer Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Business Overview
11.3.Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Merck Conjugate Vaccine Products Offered
11.3.5 Merck Recent Development
11.4 Sanofi Pasteur
11.4.1 Sanofi Pasteur Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Pasteur Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Pasteur Conjugate Vaccine Products Offered
11.4.5 Sanofi Pasteur Recent Development
11.5 CSL
11.5.1 CSL Company Details
11.5.2 Company Business Overview
11.5.3 CSL Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 CSL Conjugate Vaccine Products Offered
11.5.5 CSL Recent Development
11.6 Emergent BioSolutions
11.6.1 Emergent BioSolutions Company Details
11.6.2 Company Business Overview
11.6.3 Emergent BioSolutions Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Emergent BioSolutions Conjugate Vaccine Products Offered
11.6.5 Emergent BioSolutions Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Company Business Overview
11.7.3 Johnson & Johnson Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Johnson & Johnson Conjugate Vaccine Products Offered
11.7.5 Johnson & Johnson Recent Development
11.8 Medimmune
11.8.1 Medimmune Company Details
11.8.2 Company Business Overview
11.8.3 Medimmune Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Medimmune Conjugate Vaccine Products Offered
11.8.5 Medimmune Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Astellas Pharma Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Astellas Pharma Conjugate Vaccine Products Offered
11.9.5 Astellas Pharma Recent Development
11.10 Serum Institute of India
11.10.1 Serum Institute of India Company Details
11.10.2 Company Business Overview
11.10.3 Serum Institute of India Conjugate Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Serum Institute of India Conjugate Vaccine Products Offered
11.10.5 Serum Institute of India Recent Development
11.11 Bavarian Nordi
11.12 Mitsubishi Tanabe Pharma
11.13 Daiichi Sankyo Company
11.14 Fablife
11.15 SutroVax
11.16 Sinovac Biotech
12 Future Forecast
12.1 Conjugate Vaccine Market Forecast by Regions
12.1.1 Global Conjugate Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Conjugate Vaccine Revenue Forecast by Regions 2019-2025
12.2 Conjugate Vaccine Market Forecast by Product
12.2.1 Global Conjugate Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Conjugate Vaccine Revenue Forecast by Product 2019-2025
12.3 Conjugate Vaccine Market Forecast by End User
12.4 North America Conjugate Vaccine Forecast
12.5 Europe Conjugate Vaccine Forecast
12.6 Asia Pacific Conjugate Vaccine Forecast
12.7 Central & South America Conjugate Vaccine Forecast
12.8 Middle East and Africa Conjugate Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Conjugate Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Conjugate Vaccine Product Picture
Table Conjugate Vaccine Market Segments
Table Key Manufacturers Conjugate Vaccine Covered
Table Global Conjugate Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Conjugate Vaccine Sales Market Share by Product 2014-2025
Figure Monovalent Product Picture
Table Major Manufacturers of Monovalent
Figure Multivalent Product Picture
Table Major Manufacturers of Multivalent
Table Global Conjugate Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Clinics
Figure Conjugate Vaccine Report Years Considered
Figure Global Conjugate Vaccine Market Size 2014-2025 (Million US$)
Figure Global Conjugate Vaccine Sales 2014-2025 (K Units)
Table Global Conjugate Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Conjugate Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Conjugate Vaccine Sales Market Share by Regions 2014-2019
Figure Global Conjugate Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Conjugate Vaccine Sales Market Share by Regions
Table Global Conjugate Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Conjugate Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Conjugate Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Conjugate Vaccine Revenue Market Share by Regions
Table Global Conjugate Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Conjugate Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Conjugate Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Conjugate Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Conjugate Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Conjugate Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Conjugate Vaccine Price (2014-2019) (USD/Unit)
Table Conjugate Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Conjugate Vaccine Product Type
Table Date of International Manufacturers Enter into Conjugate Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Conjugate Vaccine Sales by Product (2014-2019) (K Units)
Table Global Conjugate Vaccine Sales Share by Product (2014-2019)
Figure Global Conjugate Vaccine Sales Market Share by Product (2014-2019)
Figure Global Conjugate Vaccine Sales Market Share by Product in 2018
Table Global Conjugate Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Conjugate Vaccine Revenue Share by Product (2014-2019)
Figure Global Conjugate Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Conjugate Vaccine Revenue Market Share by Product in 2018
Table Conjugate Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Conjugate Vaccine Sales by End User (2014-2019) (K Units)
Table Global Conjugate Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Conjugate Vaccine Market Share by End User (2014-2019)
Figure Global Sales Conjugate Vaccine Market Share by End User in 2018
Figure North America Conjugate Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Conjugate Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Conjugate Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Conjugate Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Conjugate Vaccine Sales Market Share by Countries
Table North America Conjugate Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Conjugate Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Conjugate Vaccine Revenue Market Share by Countries
Figure United States Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Conjugate Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Conjugate Vaccine Sales by Product (2014-2019) (K Units)
Table North America Conjugate Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Conjugate Vaccine Market Share by Product
Table North America Conjugate Vaccine Sales by End User (2014-2019) (K Units)
Table North America Conjugate Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Conjugate Vaccine Market Share by End User
Figure Europe Conjugate Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Conjugate Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Conjugate Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Conjugate Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Conjugate Vaccine Sales Market Share by Countries
Table Europe Conjugate Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Conjugate Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Conjugate Vaccine Revenue Market Share by Countries
Figure Germany Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Conjugate Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Conjugate Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Conjugate Vaccine Market Share by Product
Table Europe Conjugate Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Conjugate Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Conjugate Vaccine Market Share by End User
Figure Asia Pacific Conjugate Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Conjugate Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Conjugate Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Conjugate Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccine Sales Market Share by Countries
Table Asia Pacific Conjugate Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Conjugate Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccine Revenue Market Share by Countries
Figure China Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Conjugate Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Conjugate Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccine Market Share by Product
Table Asia Pacific Conjugate Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Conjugate Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Conjugate Vaccine Market Share by End User
Figure Central & South America Conjugate Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Conjugate Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Conjugate Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Conjugate Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Conjugate Vaccine Sales Market Share by Countries
Table Central & South America Conjugate Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Conjugate Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Conjugate Vaccine Revenue Market Share by Countries
Figure Brazil Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Conjugate Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Conjugate Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Conjugate Vaccine Market Share by Product
Table Central & South America Conjugate Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Conjugate Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Conjugate Vaccine Market Share by End User
Figure Middle East and Africa Conjugate Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Conjugate Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Conjugate Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Conjugate Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccine Sales Market Share by Countries
Table Middle East and Africa Conjugate Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Conjugate Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccine Revenue Market Share by Countries
Figure GCC Countries Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Conjugate Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Conjugate Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Conjugate Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Conjugate Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccine Market Share by Product
Table Middle East and Africa Conjugate Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Conjugate Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Conjugate Vaccine Market Share by End User
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Pfizer Company Details
Table Pfizer Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table CSL Company Details
Table CSL Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Recent Development
Table Emergent BioSolutions Company Details
Table Emergent BioSolutions Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Emergent BioSolutions Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Medimmune Company Details
Table Medimmune Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medimmune Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Astellas Pharma Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Conjugate Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Serum Institute of India Recent Development
Table Bavarian Nordi Company Details
Table Mitsubishi Tanabe Pharma Company Details
Table Daiichi Sankyo Company Company Details
Table Fablife Company Details
Table SutroVax Company Details
Table Sinovac Biotech Company Details
Table Global Conjugate Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Conjugate Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Conjugate Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Conjugate Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Conjugate Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Conjugate Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Conjugate Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Conjugate Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Conjugate Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Conjugate Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Conjugate Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Conjugate Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Conjugate Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Conjugate Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Conjugate Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Conjugate Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Conjugate Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Conjugate Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Conjugate Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Conjugate Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Conjugate Vaccine Value Chain
Table Conjugate Vaccine Customers List
Table Conjugate Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global HbA1c Testing Device Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Mar-2019        Price: US 3480 Onwards        Pages: 139
    HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels. 6p Scope of the Report: The global average price of HbA1c Testing Device is in the decreasing trend, from 1967 USD/Unit in 2013 to 1909 USD/Unit in 2017. With the situation of global economy, ......
  • Global Liquid Lenses Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 18-Mar-2019        Price: US 3480 Onwards        Pages: 117
    A liquid lens uses one or more fluids to create an infinitely-variable lens without any moving parts by controlling the meniscus (the surface of the liquid.) There are two primary types, Electrowetting-Based Liquid Lense and Liquid Crystal Lense. These are not to be confused with liquid-formed lenses that are created by placing a drop of plastic or epoxy on a surface, which is then allowed to harden into a lens shape. Scope of the Report: Varioptic accounted for 48.38% of ......
  • Global Iron Chelation Drug Market Data Survey Report 2013-2025
    Published: 17-Mar-2019        Price: US 1500 Onwards        Pages: 60
    Summary The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is ......
  • Global Propolis Market Data Survey Report 2013-2025
    Published: 17-Mar-2019        Price: US 1500 Onwards        Pages: 90
    Summary The global Propolis market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on company profile, sales ......
  • Global Medicinal Mushroom Extracts Market Data Survey Report 2013-2025
    Published: 16-Mar-2019        Price: US 1500 Onwards        Pages: 60
    Summary Medicinal mushrooms have long been recognized for their health benefits in Eastern medicine; traditional medicine has used mushrooms for thousands of years. Studies have found that these medicinal mushrooms contain a variety of components that act as antioxidants, support immune function, and even promote cellular health and function. The global Medicinal Mushroom Extracts market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the r......
  • Global Erythropoietin Market Data Survey Report 2013-2025
    Published: 16-Mar-2019        Price: US 1500 Onwards        Pages: 61
    Summary Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. The global Erythropoietin market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:......
  • Global High Selenium Yeast Market Data Survey Report 2013-2025
    Published: 15-Mar-2019        Price: US 1500 Onwards        Pages: 68
    Summary Selenium yeast is a form of supplemental selenium, which is also referred to as organic selenium. Selenium yeast is produced using the microorganism Saccharomyces cerevisiae, which is better known as baker's yeast or brewer's yeast. When the yeast is grown in a selenium-enriched medium, it absorbs the selenium and converts it into the form of selenium naturally found in foods, selenomethionine. The final product is used to fortify foods, fodder and to make supplements.......
  • Global Capillary Stabilizing Agents Market Growth 2019-2024
    Published: 15-Mar-2019        Price: US 3660 Onwards        Pages: 162
    Capillary Stabilizing agents are used for a number of functions in foods and the main function is to act as a thickening agent to gel the foods into the required consistency. According to this study, over the next five years the Capillary Stabilizing Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key......
  • Global Acute and Chronic Allergic Conjunctivitis Treatment Market Growth 2019-2024
    Published: 15-Mar-2019        Price: US 3660 Onwards        Pages: 130
    Swelling of conjunctiva (tissue covering white portion of eye) due to allergy is known as allergic conjunctivitis. Allergic conjunctivitis is caused due to allergens in patients such as household dust, mold spores, pollen from trees and grass, chemical scents (e.g., household detergents or perfume) and animal dander. According to this study, over the next five years the Acute and Chronic Allergic Conjunctivitis Treatment market will register a xx% CAGR in terms of revenue, the glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs